TP53-Mutated Myelodysplastic Syndrome: A Diagnostic Approach in Different Clinical Settings

Genet Test Mol Biomarkers. 2024 Jun;28(6):219-222. doi: 10.1089/gtmb.2024.0131. Epub 2024 May 6.

Authors

Hatem Kaseb^{1

2}, Genevieve Crane³, Jane Gibson¹

Affiliations

¹ Department of Clinical Sciences, Pathology, University of Central Florida College of Medicine, Orlando, Florida, USA.
² Department of Pathology, University of Central Florida Lake Nona Hospital, Orlando, Florida, USA.
³ Department of Laboratory Medicine, Cleveland Clinic Main Campus, Cleveland, Ohio, USA.

PMID: 38708593
DOI: 10.1089/gtmb.2024.0131

No abstract available

Publication types

Letter

MeSH terms

Aged
Female
Humans
Male
Middle Aged
Mutation*
Myelodysplastic Syndromes* / diagnosis
Myelodysplastic Syndromes* / genetics
Tumor Suppressor Protein p53* / genetics

Substances

Tumor Suppressor Protein p53
TP53 protein, human